Response to exercise in patients with liver cirrhosis: Implications for liver transplantation

Digestive and Liver Disease

Volumn 45, Issue 5, 2013, Pages 362-366

  Lemyze, Malcolm ^a   Dharancy, Sébastien ^b   Wallaert, Benoît ^b  

^a Schaffner Hospital   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cardiopulmonary exercise testing; Exercise; Liver cirrhosis; Liver transplant; Maximal oxygen uptake

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE;

AEROBIC CAPACITY; ALCOHOLIC CARDIOMYOPATHY; ANEMIA; BLOOD CLOTTING DISORDER; CARDIOPULMONARY EXERCISE TEST; EXERCISE; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG GAS EXCHANGE; MALNUTRITION; METABOLISM; MUSCLE ATROPHY; MUSCLE WEAKNESS; PATIENT ASSESSMENT; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; WATER RETENTION;

EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; OXYGEN CONSUMPTION; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 84876707220     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.09.022     Document Type: Review

References (51)

1. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet 2008, 371:838-851.
2. Child C.G., Turcotte J.G. Surgery and portal hypertension. Major Problems in Clinical Surgery 1964, 1:1-85.
3. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. Journal of Hepatology 2006, 44:217-231.
4. Kamath P.S., Kim W.R. The model for end-stage liver disease (MELD). Hepatology 2007, 45:797-805.
5. Jacob M., Copley L.P., Lewsey J.D., et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transplantation 2004, 10:903-907.
6. Jones N.L., Killian K.J. Exercise limitation in health and disease. New England Journal of Medicine 2000, 343:632-641.
7. Myers J., Prakash M., Froelicher V., et al. Exercise capacity and mortality among men referred for exercise testing. New England Journal of Medicine 2002, 346:793-801.
8. Wyser C., Stulz P., Solèr M., et al. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. American Journal of Respiratory and Critical Care Medicine 1999, 159:1450-1456.
9. Mancini D.M., Eisen H., Kussmaul W., et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991, 83:778-786.
10. Fletcher B.J., Dunbar S.B., Felner J.M., et al. Exercise testing and training in physically disabled men with clinical evidence of coronary artery disease. American Journal of Cardiology 1994, 73:170-174.
11. Epstein S.K., Freeman R.B., Khayat A., et al. Aerobic capacity is associated with 100-day outcome after hepatic transplantation. Liver Transplantation 2004, 10:418-424.
12. Dharancy S., Lemyze M., Boleslawski E., et al. Impact of impaired aerobic capacity on liver transplant candidates. Transplantation 2008, 86:1077-1083.
13. Prentis J.M., Manas D.M.D., Trenell M.I., et al. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transplantation 2012, 18:152-159.
14. Jones J.C., Coombes J.S., Macdonald G.A. Exercise capacity and muscle strength in patients with cirrhosis. Liver Transplantation 2012, 18:146-151.
15. Campillo B., Fouet P., Bonnet J.C., et al. Submaximal oxygen consumption in liver cirrhosis. Evidence of severe functional aerobic impairment. Journal of Hepatology 1990, 10:163-167.
16. Epstein S.K., Ciubotaru R.L., Zilberberg M.D., et al. Analysis of impaired exercise capacity in patients with cirrhosis. Digestive Diseases and Sciences 1998, 43:1701-1707.
17. Lemyze M., Dharancy S., Nevière R., et al. Cardiopulmonary response to exercise in patients with liver cirrhosis and impaired pulmonary gas exchange. Respiratory Medicine 2011, 105:1550-1556.
18. Sue D.Y., Wasserman K. Impact of integrative cardiopulmonary exercise testing on clinical decision making. Chest 1991, 99:981-992.
19. Felig P., Wahren J. Fuel homeostasis in exercise. New England Journal of Medicine 1975, 293:1078-1084.
20. Owen O.E., Trapp V.E., Reichard G.A., et al. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. Journal of Clinical Investigation 1983, 72:1821-1832.
21. Müller M.J., Lautz H.U., Plogmann B., et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992, 15:782-794.
22. Müller M.J., Fenk A., Lautz H.U., et al. Energy expenditure and substrate metabolism in ethanol-induced liver cirrhosis. American Journal of Physiology 1991, 260:E338-E344.
23. DeLissio M., Goodyear L.J., Fuller S., et al. Effects of treadmill exercise on fuel metabolism in hepatic cirrhosis. Journal of Applied Physiology 1991, 70:210-215.
24. Jones Jones N.L. Clinical exercise testing 1997, WB Saunders, Philadelphia.
25. Peng S., Plank L.D., McCall J.L., et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. American Journal of Clinical Nutrition 2007, 85:1257-1266.
26. Marchesini G., Bianchi G., Amodio P., et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001, 120:170-178.
27. Kowalski H.J., Abelmann W.H. The cardiac output at rest in Laennec's cirrhosis. Journal of Clinical Investigation 1953, 32:1025-1033.
28. Møller S., Henriksen J.H. Cirrhotic cardiomyopathy. Journal of Hepatology 2010, 53:179-190.
29. Wong F., Girgrah N., Graba J., et al. The cardiac response to exercise in cirrhosis. Gut 2001, 49:268-275.
30. Grose R.D., Nolan J., Dillon J.F., et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. Journal of Hepatology 1995, 22:326-332.
31. Gonzalez-Casas R., Jones E.A., Moreno-Otero R. Spectrum of anemia associated with chronic liver disease. World Journal of Gastroenterology 2009, 15:4653-4658.
32. 2 transport at rest, submaximal and maximal work. Journal of Applied Physiology 1978, 44:36-43.
33. Premaratna R., Sathishchandra H., Thilakaratna Y., et al. Effects of propranolol and nitrates on exercise capacity, respiratory minute volume and capillary oxygen saturation during exercise in cirrhotic patients with portal hypertension. Hepatology Research 2002, 24:152.
34. Mäki T., Näveri H., Leinonen H., et al. Effect of beta-blocking agents with and without intrinsic sympathomimetic activity on work efficiency in healthy men. Clinical Physiology 1996, 16:543-550.
35. Lemyze M., Dharancy S., Nevière R., et al. Aerobic capacity in patients with chronic liver disease: very modest effect of liver transplantation. Presse Medicale 2010, 39:e174-e181.
36. Heinemann H.O., Emirgil C., Mijnssen J.P. Hyperventilation and arterial hypoxemia in cirrhosis of the liver. American Journal of Medicine 1960, 28:239-246.
37. Krowka M.J., Cortese D.A. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest 1994, 105:1528-1537.
38. Epstein S.K., Zilberberg M.D., Jacoby C., et al. Response to symptom-limited exercise in patients with the hepatopulmonary syndrome. Chest 1998, 114:736-741.
39. Agusti A.G., Roca J., Rodriguez-Roisin R., et al. Pulmonary hemodynamics and gas exchange during exercise in liver cirrhosis. American Review of Respiratory Disease 1989, 139:485-491.
40. Katsuta Y., Honma H., Zhang X.-J., et al. Pulmonary blood transit time and impaired arterial oxygenation in patients with chronic liver disease. Journal of Gastroenterology 2005, 40:57-63.
41. Raval Z., Harinstein M.E., Skaro A.I., et al. Cardiovascular risk assessment of the liver transplant candidate. Journal of the American College of Cardiology 2011, 58:223-231.
42. Belardinelli R., Lacalaprice F., Carle F., et al. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. European Heart Journal 2003, 24:1304-1313.
43. Harinstein M.E., Flaherty J.D., Ansari A.H., et al. Predictive value of dobutamine stress echocardiography for coronary artery disease detection in liver transplant candidates. American Journal of Transplantation 2008, 8:1523-1528.
44. Sun X.G., Hansen J.E., Oudiz R.J., et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001, 104:429-435.
45. Ainsworth B.E., Haskell W.L., Herrmann S.D., et al. Compendium of physical activities: a second update of codes and MET values. Medicine and Science in Sports and Exercise 2011, 43:1575-1581.
46. Carey E.J., Steidley D.E., Aqel B.A., et al. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transplantation 2010, 16:1373-1378.
47. Stephenson A.L., Yoshida E.M., Abboud R.T., et al. Impaired exercise performance after successful liver transplantation. Transplantation 2001, 72:1161-1164.
48. Beyer N., Aadahl M., Strange B., et al. Improved physical performance after orthotopic liver transplantation. Liver Transplantation and Surgery 1999, 5:301-309.
49. Krasnoff J.B., Vintro A.Q., Ascher N.L., et al. Objective measures of health-related quality of life over 24 months post-liver transplantation. Clinical Transplantation 2005, 19:1-9.
50. Torregrosa M., Aguadé S., Dos L., et al. Cardiac alterations in cirrhosis: reversibility after liver transplantation. Journal of Hepatology 2005, 42:68-74.
51. Saltin B., Blomqvist G., Mitchell J.H., et al. Response to exercise after bed rest and after training. Circulation 1968, 38:VII1-VII78.